EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, GL Pharm Tech's enterprise value is ₩85,806 Mil.
GL Pharm Tech's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ₩24,900 Mil. Therefore, GL Pharm Tech's EV-to-Revenue for today is 3.45.
The historical rank and industry rank for GL Pharm Tech's EV-to-Revenue or its related term are showing as below:
XKRX:204840'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.19 Med: 5.85 Max: 75.04
Current: 3.45
During the past 10 years, the highest EV-to-Revenue of GL Pharm Tech was 75.04. The lowest was 2.19. And the median was 5.85.
XKRX:204840's EV-to-Revenue is ranked worse than 61.27% of 994
companies
in the Drug Manufacturers industry
Industry Median: 2.465
vs XKRX:204840: 3.45
As of today (2024-12-11), GL Pharm Tech's stock price is ₩1015.00.
GL Pharm Tech's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₩377.91. Therefore, GL Pharm Tech's PS Ratio for today is 2.69.
GL Pharm Tech EV-to-Revenue Historical Data
The historical data trend for GL Pharm Tech's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of GL Pharm Tech's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, GL Pharm Tech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GL Pharm Tech's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, GL Pharm Tech's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where GL Pharm Tech's EV-to-Revenue falls into.
GL Pharm Tech's current Enterprise Value is ₩85,806 Mil.
GL Pharm Tech's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩24,900 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GL Pharm Tech's share price for today is ₩1015.00.
GL Pharm Tech's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩377.91.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GL Pharm Tech EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of GL Pharm Tech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
GL Pharm Tech Corp is engaged in developing and marketing pharmaceutical products. It offers products including Incrementally Modified Drugs, Generic Drug and G-SOREN Tab. It also provides generic drugs for cardiovascular, gastric, diabetes, CNS, and respiratory diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:204840 has been successfully added to your 